Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Qpex Biopharma

Request full access

Developing innovative products through novel strategies for infectious diseases

San Diego, United StatesFounded 2018Biotech & Life Sciences

About Qpex Biopharma

Qpex Biopharma is a biotechnology company based in San Diego, specializing in the discovery, development, and regulatory approval of anti-infective medicines. The company focuses on creating new antibiotics to combat antimicrobial resistance, a growing global health threat. Qpex Biopharma collaborates with public-private partnerships to accelerate the development and impact of its products. The company serves healthcare providers and patients, particularly those affected by drug-resistant bacterial infections. Operating in the pharmaceutical and biotechnology markets, Qpex Biopharma generates revenue through the development and commercialization of its innovative antibiotic therapies. By leveraging its deep expertise and novel strategies, the company aims to make significant, sustainable improvements in patient care across both inpatient and outpatient settings.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
36
Open positions
3
Dealroom signal
44.8/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANTOther financing May 2024 $10M — HHS Administration for Strategic Preparedness and Response ↗
ACQUISITIONOther financing Jun 2023 $0 — Shionogi ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Qpex Biopharma website traffic

Latest recorded traffic for Qpex Biopharma is 2.9K monthly website visits, down 31% over the last three months. Qpex Biopharma's team grew 5.9% over the past year.

Latest monthly visits2.9K 3-month web change-31% 1-year team growth+5.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Proxima BioFormerly VantAI. Proximity therapeutics hijacking cellular machinery for protein degradation New York City, United States Operational 77 $80M $320M
Kolate AIAdvanced analytics platform accelerating drug development with real-time insights and competitor monitoring Montgomery Township, United States Operational
SanegeneBioDeveloping targeted RNAi-based medicines for obesity, cardiometabolic and autoimmune diseases Woburn, United States Operational
Pattern BiosciencesBuilds biomolecular computers that run molecular programs in cells to treat cancer and other diseases South San Francisco, United States Operational
BioOrbitBioOrbit is space manufacturing company developing hardware for the large-scale crystallisation of protein drugs London, United Kingdom Operational
Superluminal MedicinesGenerative biology and chemistry company revolutionizing the speed and accuracy of how medicine is created Boston, United States Operational
PhaseVUses advanced algorithms to optimize clinical trials, improving success rates, efficiency, and uncovering hidden signals in the data Tel Aviv-Yafo, Israel Operational
New BiologixEngineered cell line technology that produces safe and effective AAV drugs for gene therapy, making treatments more affordable and accessible Epalinges, Switzerland Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Qpex Biopharma in the San Diego ecosystem

Live from Dealroom

The Qpex Biopharma office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • HHS Administration for Strategic Preparedness and Response

Series A4 investors entered at this stage

Other known investors1 additional known investor

  • Shionogi
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Qpex Biopharma on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Qpex Biopharma’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.